Science Stories
Narcolepsy is a chronic, neurologic sleep disorder, and people living with the condition are at increased risk of developing cardiovascular (CV) and cardiometabolic (CM) comorbidities. New expert consensus recommendations provide more clarity on these risks, including obesity, diabetes, dyslipidemia as well as hypertension and offer actionable behavioral, therapeutic, and dietary strategies that aim to holistically mitigate these risks.
Every three minutes, someone in the U.S. is diagnosed with a blood cancer. Fast-growing blood cancers like acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) can become life-threatening if left untreated because they can quickly spread to other parts of the body, including the brain and spinal cord. Hematopoietic stem cell transplantation (HSCT) can provide an important option in improving outcomes for appropriate patients.
VOD, also known as sinusoidal obstruction syndrome, begins in the liver and can quickly affect other vital organs, most notably the kidneys and lungs. It is a rare and potentially deadly complication of hematopoietic stem cell transplantation (HSCT) occurring in approximately 9-14% of HSCT patients.
Narcolepsy is an often misunderstood and under-recognized condition. Cataplexy is a major symptom of narcolepsy, a chronic neurological condition that involves other symptoms such as excessive daytime sleepiness – that can result in difficulty focusing and maintaining alertness, along with sleep paralysis and vivid hallucinations when falling asleep or waking up.